3C Patch® Medicare Claims Study

TerminatedOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

July 15, 2020

Primary Completion Date

February 21, 2022

Study Completion Date

February 21, 2022

Conditions
Diabetic Foot Ulcer
Interventions
DEVICE

3C Patch

A platelet-rich plasma gel patch comprised of distinct fibrin, platelet, and leukocyte substantially parallel layers, prepared without the use of any added reagents through a two-step centrifugation process

Trial Locations (6)

27514

Natchitoches Regional Medical Center, Natchitoches

UNC Chapel Hill, Chapel Hill

63703

Southeast Wound Care and Hyperbaric Medical Center, Cape Girardeau

63901

Regional One Physician Specialists, Poplar Bluff

70570

Opelousas General Hospital Wound Center, Opelousas

84054

Mayo Clinic, Phoenix

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Reapplix

OTHER

NCT03997526 - 3C Patch® Medicare Claims Study | Biotech Hunter | Biotech Hunter